Literature DB >> 19121307

Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant.

Hauke Schmidt1, Jenni Raasch, Doron Merkler, Florian Klinker, Sandra Krauss, Wolfgang Brück, Marco Prinz.   

Abstract

The type I interferons, interferon-beta and alpha (IFN-beta, IFN-alpha), are widely used for the treatment of autoimmune demyelination in the central nervous system (CNS). Their effects on de- and remyelination through the broadly expressed type I IFN receptor (IFNAR), however, are highly speculative. In order to elucidate the role of endogenous type I interferons for myelin damage and recovery we induced toxic demyelination in the absence of IFNAR1. We demonstrate that IFNAR signalling was induced during acute demyelination since the cytokine IFN-beta as well as the IFN-dependent genes IRF7, ISG15 and UBP43 were strongly upregulated. Myelin damage, astrocytic and microglia response, however, were not significantly reduced in the absence of IFNAR1. Furthermore, motor skills of IFNAR1-deficient animals during non-immune demyelination were unaltered. Finally, myelin recovery was found to be independent from endogenous IFNAR signalling, indicating a redundant role of this receptor for non-inflammatory myelin damage and repair.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19121307     DOI: 10.1016/j.expneurol.2008.12.002

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

1.  Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells.

Authors:  Jui-Hung Yen; Weimin Kong; Kirsten M Hooper; Frances Emig; Kate M Rahbari; Ping-Chang Kuo; Barbara A Scofield; Doina Ganea
Journal:  J Leukoc Biol       Date:  2015-06-09       Impact factor: 4.962

2.  TREM2 sustains microglial expansion during aging and response to demyelination.

Authors:  Pietro Luigi Poliani; Yaming Wang; Elena Fontana; Michelle L Robinette; Yoshinori Yamanishi; Susan Gilfillan; Marco Colonna
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

Review 3.  Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS.

Authors:  Tobias D Merson; Michele D Binder; Trevor J Kilpatrick
Journal:  Neuromolecular Med       Date:  2010-03-30       Impact factor: 3.843

4.  ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation.

Authors:  Benjamin D S Clarkson; Ethan Grund; Kenneth David; Renee K Johnson; Charles L Howe
Journal:  J Neuroinflammation       Date:  2022-10-20       Impact factor: 9.587

5.  Transcriptional expression patterns triggered by chemically distinct neuroprotective molecules.

Authors:  D J Pappas; P A Gabatto; D Oksenberg; P Khankhanian; S E Baranzini; L Gan; J R Oksenberg
Journal:  Neuroscience       Date:  2012-09-15       Impact factor: 3.590

Review 6.  Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination.

Authors:  Martin Zirngibl; Peggy Assinck; Anastasia Sizov; Andrew V Caprariello; Jason R Plemel
Journal:  Mol Neurodegener       Date:  2022-05-07       Impact factor: 18.879

7.  Type I interferons as ambiguous modulators of chronic inflammation in the central nervous system.

Authors:  Marco Prinz; Klaus-Peter Knobeloch
Journal:  Front Immunol       Date:  2012-04-09       Impact factor: 7.561

Review 8.  Hypersensitivity Responses in the Central Nervous System.

Authors:  Reza Khorooshi; Nasrin Asgari; Marlene Thorsen Mørch; Carsten Tue Berg; Trevor Owens
Journal:  Front Immunol       Date:  2015-10-07       Impact factor: 7.561

Review 9.  Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis.

Authors:  Renaud A Du Pasquier; Daniel D Pinschewer; Doron Merkler
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

Review 10.  Immune heterogeneity in neuroinflammation: dendritic cells in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-01       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.